A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, manufactured by Novo Nordisk. Reuters Eli Lilly said Wednesday that its obesity drug Zepbound ...
US households with users of GLP-1 drugs like Ozempic spend 6-9% less on groceries, with ultra-processed foods seeing the ...
As the weight-loss drugs become more popular, consumer habits are starting to reflect changing consumption behavior, ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
Tirzepatide, a weekly GLP-1 and GIP drug, produced weight loss of up to 17.8% after 72 weeks. Semaglutide, a weekly GLP-1 ...
Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 492.13% and ...
Kwame Raoul’s office sent cease and desist letters to five unnamed medical spas in the Chicago area that were allegedly ...
Indiana’s Medicaid program estimates the Biden administration’s proposal to expand coverage of weight-loss treatment for ...
2024 was quite a year for significant strategic action among the pharmaceutical giants. Here are five key trends that will ...
Expanding volumes of data point to mechanisms beyond weight loss and blood sugar control that contribute to cardiovascular ...
A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback